Search Orphan Drug Designations and Approvals
-
Generic Name: | Dendritic cell/tumor cell fusion vaccine + recombinant human interleukin 12 |
---|---|
Date Designated: | 01/25/2017 |
Orphan Designation: | Treatment of malignant glioma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
CyTIX Inc. 7F Terada Bldg, 2-3-3 Shibakoen Minato-ku, Tokyo Japan The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-